News

London, 24 January 2024 – Kadans Science Partner (“Kadans”) has received planning approval from Cambridge City Council for the development of a new, purpose-built laboratory and office building at Merlin Place, Cambridge, a new Gateway Building for the Cambridge North Cluster.

Arecor Therapeutics plc

(“Arecor” or the “Company”)


ARECOR ANNOUNCES UPDATE ON INBRX-101


- Sanofi to acquire Inhibrx’s AATD therapy INBRX-101, which incorporates a novel formulation developed under a license agreement using Arecor’s Arestat™ technology, for up to $2.2 billion

- Terms of Arecor’s license agreement are unchanged. Arecor remains entitled to further payments on achievement of certain development, regulatory and commercial milestones along with annual Technology Access Fees post commercialisation

Arecor Therapeutics plc

(“Arecor” or the “Group”)


ARECOR GRANTED KEY EUROPEAN PATENT EXTENDING PROTECTION FOR INSULIN PRODUCTS, AT278 AND AT247

Apply now to participate in the next Pioneer Accelerator Programme designed to help businesses launch, grow and scale. 


Available programmes include: 



  • Pioneer Group Accelerator Programme, Ireland

  • Health Innovation East Midlands NHS Programme

  • Pioneer Group Accelerator Programme, England & Wales

  • Pioneer Group Accelerator Programme, Scotland 


 


For more information, please visit: https://thepioneergroup.com/accelerator-programme/


AMSBIO has launched a new 2024 travel grant award scheme for scientists under the age of thirty, employed in academia, research institutions, or companies engaged in cancer and stem cell research.


  • Strategic partnership harnesses respective organ-specific expertise to provide complete human-derived Organ-on-a-Chip solution for more accurate in vitro ADME predictions  

  • Early access to dual-organ model available through CN Bio’s Contract Research Services 


 


In the first People Pathways edition of the year, we are thrilled to bring you our 4th annual Building Life Sciences Adventures (BLSA) Conference and wanted to share a glimpse of the exiting journey that lies ahead. 

Click here to read about:
✳ Top 5 reasons why you should sponsor BLSA...

Excitement is in the air as we approach our Annual Awards Dinner on 21 March 2024, at stunning London venue, No.11 Cavendish Square. 


Get your nominations in and be part of an evening that recognises and celebrates the success of our community. Remember, you have the opportunity to nominate either your own company or a company you've worked with to acknowledge their exceptional performance. Entries close on 7 February.


Categories


Chesterford Research Park, set in over 250 acres of idyllic countryside, makes business meetings an unexpected pleasure, training and team building exercises a talking point and even the simplest of functions memorable.

Mayer Schreiber, CEO of Discovery Park, and Chris Broom, Head of Business Development at Discovery Park, recently attended the JP Morgan Healthcare Conference in San Francisco to build global connections and raise awareness of the opportunities in the UK for the biotech industry, as well as exploring opportunities for Discovery Park Ventures and its portfolio companies. The conference brought together thousands of industry experts from across the globe to discuss the biggest challenges and opportunities for 2024 and beyond.

Pages